Envíos recientes

What if the future of HER2-positive breast cancer patients was written in miRNAs? An exploratory analysis from NeoALTTO study

Cosentino, Giulia; Cataldo, Alessandra; Plantamura, Ilaria; Nuciforo, Paolo Giovanni; Ciniselli, Chiara Maura; Pizzamiglio, Sara; De Cecco, Loris (Fecha de publicación: 2022-06-27)

HER2; MicroRNA; Trastuzumab

CRISPR/Cas9 screens identify LIG1 as a sensitizer of PARP inhibitors in castration-resistant prostate cancer

Fracassi, Giulia; Lorenzin, Francesca; Orlando, Francesco; Gioia, Ubaldo; D'Amato, Giacomo; Solé Casaramona, Arnau; Mateo, Joaquin (Fecha de publicación: 2025-03-11)

DNA repair; Oncology; Prostate cancer

Analysis of cell free DNA to predict outcome to bevacizumab therapy in colorectal cancer patients

Venken, Tom; Miller, Ian; Arijs, Ingrid; Thomas, Valentina; Barat, Ana; Betge, Johannes; Serna, Garazi; Nuciforo, Paolo (Fecha de publicación: 2024-06-03)

Cell free DNA; Bevacizumab; Colorectal cancer

Patient-reported outcomes and tolerability in patients receiving ripretinib versus sunitinib after treatment with imatinib in INTRIGUE, a phase 3, open-label study

Gelderblom, Hans; Jones, Robin; Blay, Jean-Yves; George, Suzanne; von Mehren, Margaret; Zalcberg, John; Serrano, Cesar (Fecha de publicación: 2023-08-31)

Gastrointestinal stromal tumours; Patient reported outcome measures; Protein kinase inhibitors

The Medical Oncology resident mentor: situation and workload

Elez Fernandez, Mª Elena; Quintanar, T.; Bosch-Barrera, J; Corral, J.; Lainez, N.; Moreno, Victor (Fecha de publicación: 2021-03-11)

Oncologia mèdica; Mentor resident; Càrrega de treball

First-in-human, dose-escalation, phase 1 study of anti-angiopoietin-2 LY3127804 as monotherapy and in combination with ramucirumab in patients with advanced solid tumours

Martín Liberal, Juan Jesús; Jungels, Christiane; Martin-Romano, Patricia; Rodon Ahnert, Jordi; Aftimos, Philippe; Hollebecque, Antoine (Fecha de publicación: 2021-11-11)

Desenvolupament de fàrmacs

Short-course radiotherapy for rectal cancer: real-world evidence in Argentina

Freile, Berenice; Galli, Mariana; Sanchez Loria, Fernando; Tissera, Natalia Soledad; Waisberg, Federico; Esteso, Federico (Fecha de publicación: 2023-09-20)

Latin America; Rectal cancer; Short-course radiotherapy

Nanrilkefusp alfa (SOT101), an IL-15 receptor βγ superagonist, as a single agent or with anti-PD-1 in patients with advanced cancers

CASSIER, Philippe; Gomez-Roca, Carlos; Korakis, Iphigenie; Champiat, Stephane; GARRALDA, Elena; Galvao, Vladimir (Fecha de publicación: 2025-04-25)

Anti-tumor efficacy; Pembrolizumab combination; Solid tumors

Anti-Ebola virus mAb 3A6 protects highly viremic animals from fatal outcome via binding GP(1,2) in a position elevated from the virion membrane

Hastie, Kathryn; Li, Zhe; Ke, Zunlong; Halfmann, Peter; DeWald, Lisa Evans; McArdle, Sara; Grinyo i Escuer, Ariadna (Fecha de publicación: 2025-04-08)

Ebola virus; Virion membrane

Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group

Mosele, Maria; Stenzinger, Albrecht; Bayle, Arnaud; Bieche, Ivan; Westphalen, Benedikt; Barlesi, Fabrice; Dienstmann, Rodrigo; Serrano, Cesar; Mateo, Joaquin (Fecha de publicación: 2024-06-27)

Advanced cancer; Next-generation sequencing; Precision medicine

Multimodal data integration in early-stage breast cancer

Llinas-Bertran, Arnau; Butjosa-Espín, Maria; Barberi, Vittoria; Seoane Fernández, Jose Antonio (Fecha de publicación: 2025-03-21)

Deep learning; Multi-omics; Multimodal data integration

Genetic immune escape landscape in primary and metastatic cancer

Martínez-Jiménez, Francisco; Priestley, Peter; Shale, Charles; Baber, Jonathan; Rozemuller, Erik; Cuppen, Edwin (Fecha de publicación: 2023-07-04)

Genome; Tumour immunology

Mirvetuximab soravtansine in folate receptor alpha (FRα)–high platinum-resistant ovarian cancer: final overall survival and post hoc sequence of therapy subgroup results from the SORAYA trial

Coleman, Robert; Cecere, Sabrina Chiara; Lorusso, Domenica; OAKNIN, ANA; denys, hannelore; Colombo, Nicoletta (Fecha de publicación: 2024-10-04)

Ovarian Cancer

Early treatment discontinuation in patients with deficient mismatch repair or microsatellite instability high metastatic colorectal cancer receiving immune checkpoint inhibitors

Alouani, Emily; Sinicrope, Frank; Decraecker, Marie; Ros Codoñer, Javier; taieb, julien; Ambrosini, Margherita; Lonardi, Sara (Fecha de publicación: 2025-03-21)

Colorectal cancer; Immune checkpoint inhibitor; Microsatellite

Phenotypic characterization of spatial immune infiltration niches in non-small cell lung cancer

Sandström Gerdtsson, Anna; Knulst, Mattis; Botling, Johan; Mezheyeuski, Artur; Micke, Patrick; Ek, Sara (Fecha de publicación: 2023-05-10)

Immune infiltration; Spatial omics; Tertiary lymphoid structures

First-in-Human Phase I Study of a CD16A Bispecific Innate Cell Engager, AFM24, Targeting EGFR-Expressing Solid Tumors

El-Khoueiry, Anthony; Thomas, Jacob; Livings, Claire; Hintzen, Gabriele; Saavedra, Omar; GARRALDA, Elena (Fecha de publicación: 2025-04-22)

Bispecific innate cell engager; Solid tumors

MODUL cohort 2: an adaptable, randomized, signal-seeking trial of fluoropyrimidine plus bevacizumab with or without atezolizumab maintenance therapy for BRAFwt metastatic colorectal cancer

Tabernero Caturla, Josep; Grothey, Axel; Arnold, Dirk; Ducreux, M.; O’Dwyer, P.; de Gramont, Aimery (Fecha de publicación: 2022-10-27)

Atezolizumab; Bevacizumab; Metastatic colorectal cancer

Articles científics - VHIO: Envíos recientes

What if the future of HER2-positive breast cancer patients was written in miRNAs? An exploratory analysis from NeoALTTO study

CRISPR/Cas9 screens identify LIG1 as a sensitizer of PARP inhibitors in castration-resistant prostate cancer

Analysis of cell free DNA to predict outcome to bevacizumab therapy in colorectal cancer patients

Patient-reported outcomes and tolerability in patients receiving ripretinib versus sunitinib after treatment with imatinib in INTRIGUE, a phase 3, open-label study

The Medical Oncology resident mentor: situation and workload

First-in-human, dose-escalation, phase 1 study of anti-angiopoietin-2 LY3127804 as monotherapy and in combination with ramucirumab in patients with advanced solid tumours

Short-course radiotherapy for rectal cancer: real-world evidence in Argentina

Nanrilkefusp alfa (SOT101), an IL-15 receptor βγ superagonist, as a single agent or with anti-PD-1 in patients with advanced cancers

Anti-Ebola virus mAb 3A6 protects highly viremic animals from fatal outcome via binding GP(1,2) in a position elevated from the virion membrane

Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group

Multimodal data integration in early-stage breast cancer

Genetic immune escape landscape in primary and metastatic cancer

Mirvetuximab soravtansine in folate receptor alpha (FRα)–high platinum-resistant ovarian cancer: final overall survival and post hoc sequence of therapy subgroup results from the SORAYA trial

Early treatment discontinuation in patients with deficient mismatch repair or microsatellite instability high metastatic colorectal cancer receiving immune checkpoint inhibitors

Phenotypic characterization of spatial immune infiltration niches in non-small cell lung cancer

First-in-Human Phase I Study of a CD16A Bispecific Innate Cell Engager, AFM24, Targeting EGFR-Expressing Solid Tumors

MODUL cohort 2: an adaptable, randomized, signal-seeking trial of fluoropyrimidine plus bevacizumab with or without atezolizumab maintenance therapy for BRAFwt metastatic colorectal cancer

PP2A-B55 phosphatase counteracts Ki-67-dependent chromosome individualization during mitosis

Digital Microscopy Augmented by Artificial Intelligence to Interpret Bone Marrow Samples for Hematological Diseases

Syndecan-3 positively regulates the pro-inflammatory function of macrophages

Articles científics - VHIO: Envíos recientes

What if the future of HER2-positive breast cancer patients was written in miRNAs? An exploratory analysis from NeoALTTO study ﻿

CRISPR/Cas9 screens identify LIG1 as a sensitizer of PARP inhibitors in castration-resistant prostate cancer ﻿

Analysis of cell free DNA to predict outcome to bevacizumab therapy in colorectal cancer patients ﻿

Patient-reported outcomes and tolerability in patients receiving ripretinib versus sunitinib after treatment with imatinib in INTRIGUE, a phase 3, open-label study ﻿

The Medical Oncology resident mentor: situation and workload ﻿

First-in-human, dose-escalation, phase 1 study of anti-angiopoietin-2 LY3127804 as monotherapy and in combination with ramucirumab in patients with advanced solid tumours ﻿

Short-course radiotherapy for rectal cancer: real-world evidence in Argentina ﻿

Nanrilkefusp alfa (SOT101), an IL-15 receptor βγ superagonist, as a single agent or with anti-PD-1 in patients with advanced cancers ﻿

Anti-Ebola virus mAb 3A6 protects highly viremic animals from fatal outcome via binding GP(1,2) in a position elevated from the virion membrane ﻿

Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group ﻿

Multimodal data integration in early-stage breast cancer ﻿

Genetic immune escape landscape in primary and metastatic cancer ﻿

Mirvetuximab soravtansine in folate receptor alpha (FRα)–high platinum-resistant ovarian cancer: final overall survival and post hoc sequence of therapy subgroup results from the SORAYA trial ﻿

Early treatment discontinuation in patients with deficient mismatch repair or microsatellite instability high metastatic colorectal cancer receiving immune checkpoint inhibitors ﻿

Phenotypic characterization of spatial immune infiltration niches in non-small cell lung cancer ﻿

First-in-Human Phase I Study of a CD16A Bispecific Innate Cell Engager, AFM24, Targeting EGFR-Expressing Solid Tumors ﻿

MODUL cohort 2: an adaptable, randomized, signal-seeking trial of fluoropyrimidine plus bevacizumab with or without atezolizumab maintenance therapy for BRAFwt metastatic colorectal cancer ﻿

PP2A-B55 phosphatase counteracts Ki-67-dependent chromosome individualization during mitosis ﻿

Digital Microscopy Augmented by Artificial Intelligence to Interpret Bone Marrow Samples for Hematological Diseases ﻿

Syndecan-3 positively regulates the pro-inflammatory function of macrophages ﻿

What if the future of HER2-positive breast cancer patients was written in miRNAs? An exploratory analysis from NeoALTTO study

CRISPR/Cas9 screens identify LIG1 as a sensitizer of PARP inhibitors in castration-resistant prostate cancer

Analysis of cell free DNA to predict outcome to bevacizumab therapy in colorectal cancer patients

Patient-reported outcomes and tolerability in patients receiving ripretinib versus sunitinib after treatment with imatinib in INTRIGUE, a phase 3, open-label study

The Medical Oncology resident mentor: situation and workload

First-in-human, dose-escalation, phase 1 study of anti-angiopoietin-2 LY3127804 as monotherapy and in combination with ramucirumab in patients with advanced solid tumours

Short-course radiotherapy for rectal cancer: real-world evidence in Argentina

Nanrilkefusp alfa (SOT101), an IL-15 receptor βγ superagonist, as a single agent or with anti-PD-1 in patients with advanced cancers

Anti-Ebola virus mAb 3A6 protects highly viremic animals from fatal outcome via binding GP(1,2) in a position elevated from the virion membrane

Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group

Multimodal data integration in early-stage breast cancer

Genetic immune escape landscape in primary and metastatic cancer

Mirvetuximab soravtansine in folate receptor alpha (FRα)–high platinum-resistant ovarian cancer: final overall survival and post hoc sequence of therapy subgroup results from the SORAYA trial

Early treatment discontinuation in patients with deficient mismatch repair or microsatellite instability high metastatic colorectal cancer receiving immune checkpoint inhibitors

Phenotypic characterization of spatial immune infiltration niches in non-small cell lung cancer

First-in-Human Phase I Study of a CD16A Bispecific Innate Cell Engager, AFM24, Targeting EGFR-Expressing Solid Tumors

MODUL cohort 2: an adaptable, randomized, signal-seeking trial of fluoropyrimidine plus bevacizumab with or without atezolizumab maintenance therapy for BRAFwt metastatic colorectal cancer

PP2A-B55 phosphatase counteracts Ki-67-dependent chromosome individualization during mitosis

Digital Microscopy Augmented by Artificial Intelligence to Interpret Bone Marrow Samples for Hematological Diseases

Syndecan-3 positively regulates the pro-inflammatory function of macrophages